The purpose of our study is to assess the impact of different disbursement protocols in morphological changes that arise in the grafting of cryopreserved human saphenous veins. This study was conducted on twelve saphenous vein grafts harvested on brain death donors. Storage in the liquid nitrogen phase for 3 or 5 years is followed. Two Disbursement Protocols are tested: 1. Giving birth in the refrigerator at + 4 ° C for 2 hours. 2. Fast Disbursement – In Tub Water at + 37 ° C. Graft is processed to scan an electron microscope. Comparison of continuous parameters in the study between experimental groups is carried out using T-Test (age, cold ischemic time, Cryoprotectant exposure, time of storage, total disbursement time, melting average, melted HSVG morphological assessment) and median test (HSVG length).

Categorical parameters (gender, blood group) are officially tested using the Chi-Square test. All samples are evaluated in accordance with morphological changes and scores in terms of mutually morphological endothelium, endothelum that supports structural inhomogenity, endothelial cell separation, separation, loss of endothelium and damage to the subendotial layer. There was no statistically significant difference between the sample set at a significance level of 0.05. There is no relationship with donor ages, gender and storage time. Graft Vena Saphenous Cryopreserved in our experimental work does not show the difference in terms of structural damage to endothelial surfaces and basal membranes depending on the liquefaction protocol used.

Cryopreserved human umbilical straps versus dermal acellular matrix patches for improving the Fetal Spina Bifida Fetal in the Pregnant Mouse Model.

Apart from a significant increase in the spinal cord function after the improvement of the Utero Spina Bifida (SB) compared to traditional postnatal improvements, more than half of the children who undergo this procedure did not benefit fully. The lack of benefits has been associated with the method of closing defects, with the next spinal cord tethering on the repair site. Therefore, regenerative fillings or materials with anti-inflammatory and anti-scar properties can relieve comorbidity with improved results.

Therefore the main goal of the author to compare the umbilical cable of the human cryopreserved (HUC) versus acellular dermal matrix (ADM) for regenerative repairs in the Uterero SB lesion in the animal model. In Vivo’s studies were carried out in the defect of SB which was induced by Retino acid in the Fetus of the Tikus Sprague-Dawley. Huc or ADM patches are sewn on the disability of SB at a 20 day gestation. The SB defective network that was repaired was harvested after 48-52 hours.

The network section is directed immunofluorescent to the existence of neutrophils, macrophages, keratinocytes, meningeal cells, and astrocytes and for related apoptosis. Experiments of cokultur meningeal cells or keratinocytes with ADM patch and HUC are carried out. All experiments are considered quantitatively in a blind manner. Nekrofil counts and lower apoptosis cells in the HUC-based improvement group (N = 8) rather than in the admin repair group (n = 7).

In the Huc Patch Repair Group, Keratinocytes are present on the outer surface of the patch, the meningeal cell is present on the surface of the inner surface adjacent to the neurlassode, and the astrocyte is not recorded. In the ADM patch repair group, all 3 types of cells are on both patch surfaces. In vitro studies show that human meningeal cells grow specially on the Mesenchymal Patch Huc side, while keratinocytes show tropism for the epithelial side, indicating the polarity based cells based. In contrast, ADM patch studies do not show the polarity and decrease in cellular infiltration.

A strong protocol for the free feeder adaptation of Cryopreserved pluripotent stem cells.

Human pluripotent stem cells (HPSCs) are managed conventionally in the embryon fibroblast feeder (MEF) mouse layer. However, downstream applications, such as directed differentiation protocols, are mainly optimized for Feeder-Free culture. Therefore, HPSCs must often be adapted to the free condition of the feeder. Here we propose a new free feeder adaptation protocol using Stemflex media, which can be directly applied to the liqueficible HPSC line. The free adaptation protocol of the feeder directly using Stemflex’s culture media in the Geltrex layer causes a strong HPSC culture in about 2 weeks.

This approach was tested with three human embryonic stem cell lines (HESC). All lines are confirmed to be pluripotent, expressing POU5F1, SOX2, and Nanog. No chromosome imbalance induced by the adaptation of feeder-free protocol is easily implemented in the laboratory that conducts a free culture of feeders, allowing more comfortable adaptation and stronger expansion of HPSC cryopreserved, even in cases when the sample quality is low or unknown.

The effects of human amniotic membranes cryopreserved on healing fracture: studies of animals.

The purpose of this study was to investigate the effects of human amniotic membranes (HAM) in healing fractures on animal models. Tibial diapial fractures can be created in twenty eight wistar-albino rats and treated with Kirschner intramedulller (K-Wire) wire and human rights (HAM (+)) or K-wire group (HAM (-)). Fracture healing is evaluated with histological analysis, radiological x-ray display and callus diameter measurement in 3 and 6 weeks postoperative postoperatively better in human rights group (+) and the difference is statistically significant in the 3rd and 6th week of post operation (p <0.05). The highest histological score and all the formation of woven bones (HUO Stage 8-9) was obtained in 6 weeks after surgery in the human rights group (+). Histological examination also revealed the dominant fibrous network and the formation of partial cartilage (HUO stage 2) in the 3rd week after surgery in the human rights group (-).

T-Pro MycoClean spray
JT90-R002	T-Pro Biotechnology	500ml/BT	EUR 172.8

CD4+ T cells, Negatively Selected (Human)
79752	BPS Bioscience	10 million cells	EUR 395
Description: Cryopreserved vial (10 x 10^6 cells) of CD4+ T cells that were negatively selected from freshly isolated primary human peripheral blood mononuclear cells (PBMCs). The PBMCs came from a healthy donor, and were isolated from whole blood or leukapheresis samples using a Ficoll gradient. Magnetic antibodies to monocytes, granulocytes, CD8+ T cells, gamma/delta T cells and other immune subsets present in PBMCs were then used to purify untouched CD4+ T cells via immunomagnetic separation. Before and after CD4+ T cell isolation, the cells were stained to evaluate purity and viability by flow cytometry. Cells were cryopreserved in CryoStor CS10 cryopreservation medium (Stemcell, #07930) at a controlled rate._x000D_Source Normal human PBMC from Leukapheresis Sample

CD8+ T cells, Negatively Selected (Human)
79753	BPS Bioscience	10 million cells	EUR 495
Description: Cryopreserved vial (10 x 10^6 cells) of CD8+ T cells that were negatively selected from freshly isolated primary human peripheral blood mononuclear cells (PBMCs). The PBMCs came from a healthy donor, and were isolated from whole blood or leukapheresis samples using a Ficoll gradient. Magnetic antibodies to monocytes, granulocytes, CD4+ T cells, gamma/delta T cells and other immune subsets present in PBMCs were then used to purify untouched CD8+ T cells via immunomagnetic separation. Before and after CD8+ T cell isolation, the cells were stained to evaluate purity and viability by flow cytometry. Cells were cryopreserved in CryoStor CS10 cryopreservation medium (Stemcell, #07930) at a controlled rate._x000D_Source Normal human PBMC from Leukapheresis Sample

T-Pro EZ Gel Solution 8%
JB02-B008M	T-Pro Biotechnology	500ml/BT	EUR 266.4

T-Pro EZ Gel Solution 8%
JB02-B008S	T-Pro Biotechnology	100ml/BT	EUR 162

T-Pro EZ Gel Solution 10%
JB02-B010M	T-Pro Biotechnology	500ml/BT	EUR 266.4

T-Pro EZ Gel Solution 10%
JB02-B010S	T-Pro Biotechnology	100ml/BT	EUR 162

T-Pro EZ Gel Solution 12%
JB02-B012M	T-Pro Biotechnology	500ml/BT	EUR 266.4

T-Pro EZ Gel Solution 12%
JB02-B012S	T-Pro Biotechnology	100ml/BT	EUR 162

T-Pro EZ Gel Solution 15%
JB02-B015M	T-Pro Biotechnology	500ml/BT	EUR 266.4

T-Pro EZ Gel Solution 15%
JB02-B015S	T-Pro Biotechnology	100ml/BT	EUR 162

T-Pro Separating or Resolving Buffer
JB03-C001	T-Pro Biotechnology	500ml/BT	EUR 182.4

T-Pro BCA Protein Assay kit
JB04-D001	T-Pro Biotechnology	500assay/KIT	EUR 244.8

T-Pro Transfer Blotting buffer (10X)
JB08-H001	T-Pro Biotechnology	500ml/BT	EUR 162

T-Pro Western Blot Stripping Reagent
JB11-K002	T-Pro Biotechnology	500ml/BT	EUR 213.6

T-Pro Aqua EZ Clean (M)
JT90-R001M	T-Pro Biotechnology	500ml/BT	EUR 398.4

T-Pro Aqua EZ Clean (S)
JT90-R001S	T-Pro Biotechnology	100ml/BT	EUR 181.2

T-Pro EZ stain Gel solution
JT90-R005M	T-Pro Biotechnology	500ml/BT	EUR 224.4

T-Pro EZ stain Gel solution
JT90-R005S	T-Pro Biotechnology	100ml/BT	EUR 151.2

T-Pro P-Fect Transfection Reagent
JT97-N005M	T-Pro Biotechnology	1.0ml/vial	EUR 266.4

T-Pro Plasmid Mini Kit (100)
RB94-YPD100	T-Pro Biotechnology	100preps/Kit	EUR 193.2

T-Pro Plasmid Mini Kit (250)
RB94-YPD250	T-Pro Biotechnology	250preps/Kit	EUR 266.4

T-Pro Plasmid Midi Kit (20)
RB94-YPI020	T-Pro Biotechnology	20preps/Kit	EUR 255.6

T-Pro Plasmid Maxi Kit (10)
RB94-YPM010	T-Pro Biotechnology	10preps/Kit	EUR 266.4

T-Pro BCA Protein Assay Reagent A
JB04-D001A	T-Pro Biotechnology	500ml/BT	EUR 204

T-Pro BCA Protein Assay Reagent B
JB04-D001B	T-Pro Biotechnology	12ml/BT	EUR 140.4

T-Pro Bradford Protein Assay kit(1X)
JB04-D002	T-Pro Biotechnology	500ml/BT	EUR 193.2

T-Pro Fast Blocking Buffer (in PBS)
JK92-W001	T-Pro Biotechnology	500ml/BT	EUR 224.4

T-Pro Fast Blocking Buffer (in TBS)
JK92-W002	T-Pro Biotechnology	500ml/BT	EUR 224.4

T-Pro Genomic DNA Midi Kit (20)
RB94-NGM020	T-Pro Biotechnology	20preps/kit	EUR 266.4

T-Pro Genomic DNA Mini Kit (100)
RB94-NGS100	T-Pro Biotechnology	100preps/kit	EUR 255.6

T-Pro Laemmli (SDS sample) Reagent (reducing 4X)
JB06-F002	T-Pro Biotechnology	10ml/BT	EUR 151.2

T-Pro Tris-Glycine-SDS running buffer (10X)
JB07-G001	T-Pro Biotechnology	500ml/BT	EUR 162

T-Pro Tris-Glycine-Native running buffer (10X)
JB07-G002	T-Pro Biotechnology	500ml/BT	EUR 162

T-Pro Semi Dry Transfer Blotting buffer (10X)
JB08-H002	T-Pro Biotechnology	500ml/BT	EUR 172.8

T-Pro Protein Free Blocking Buffer (in PBS)
JK92-W003	T-Pro Biotechnology	500ml/BT	EUR 224.4

T-Pro Protein Free Blocking Buffer (in TBS)
JK92-W004	T-Pro Biotechnology	500ml/BT	EUR 224.4

T-Pro Nonliposomal Transfection Reagent I (NTR I)
JT97-N001M	T-Pro Biotechnology	1.0ml/vial	EUR 224.4

T-Pro Nonliposomal Transfection Reagent II (NTR II)
JT97-N002M	T-Pro Biotechnology	1.0ml/vial	EUR 244.8

T-Pro Nonliposomal Transfection Reagent III (NTR III)
JT97-N006M	T-Pro Biotechnology	1.0ml/vial	EUR 266.4

T-Pro Endotoxin Removal Plasmid Midi kit (25)
RB94-EPI020	T-Pro Biotechnology	20preps/Kit	EUR 297.6

T-Pro Endotoxin Removal Plasmid Maxi kit (10)
RB94-EPM010	T-Pro Biotechnology	10preps/Kit	EUR 318

T-Pro Plant Genomic DNA Midi Kit (20)
RB94-PGM020	T-Pro Biotechnology	20preps/kit	EUR 266.4

T-Pro Plant Genomic DNA Mini Kit (100)
RB94-PGS100	T-Pro Biotechnology	100preps/kit	EUR 266.4

T-Pro Laemmli (SDS sample) Reagent (non-reducing 4X)
JB06-F003	T-Pro Biotechnology	10ml/BT	EUR 151.2

T-Pro LumiFast Plus Chemiluminescence Detection Kit (ECL Kit)
JT96-K002M	T-Pro Biotechnology	250ml*2/Kit	EUR 244.8

T-Pro LumiFast Plus Chemiluminescence Detection Kit (ECL Kit)
JT96-K002S	T-Pro Biotechnology	100ml*2/Kit	EUR 182.4

T-Pro LumiLong Plus Chemiluminescence Detection Kit (ECL Kit)
JT96-K004M	T-Pro Biotechnology	250ml*2/Kit	EUR 286.8

T-Pro LumiLong Plus Chemiluminescence Detection Kit (ECL Kit)
JT96-K004S	T-Pro Biotechnology	100ml*2/Kit	EUR 204

T-Pro Gel/PCR DNA Purification Maxi Kit (10)
RB94-NEL010	T-Pro Biotechnology	10preps/Kit	EUR 193.2

T-Pro Gel/PCR DNA Purification Mini Kit (100)
RB94-NES100	T-Pro Biotechnology	100preps/Kit	EUR 193.2

T-Pro Gel/PCR DNA Purification Mini Kit (250)
RB94-NES250	T-Pro Biotechnology	250preps/Kit	EUR 266.4

T-Pro Washing buffer in PBS and Tween-20 (10X)
JB09-I003	T-Pro Biotechnology	500ml/BT	EUR 172.8

T-Pro Washing buffer in TBS and Tween-20 (10X)
JB09-I004	T-Pro Biotechnology	500ml/BT	EUR 172.8

T-Pro Phosphate-Buffered Saline (PBS, 10X) for western blot washing
JB09-I001	T-Pro Biotechnology	500ml/BT	EUR 162

T-Pro Tris-Buffered Saline (TBS, 10X) for western blot washing
JB09-I002	T-Pro Biotechnology	500ml/BT	EUR 162

Untransduced T Cells
78170-1	BPS Bioscience	1 vial	EUR 1250
Description: The untransduced T cells are produced by mock lentiviral transduction of human primary CD4+CD8+ T cells. These cells are subjected to comparable manipulations as CAR-T cells: activation, spinoculation (without lentivirus), and expansion. These T cells are meant to be negative controls in experiments using lentivirus-transduced primary CAR-T cells.

Untransduced T Cells
78170-2	BPS Bioscience	5 vials	EUR 3325
Description: The untransduced T cells are produced by mock lentiviral transduction of human primary CD4+CD8+ T cells. These cells are subjected to comparable manipulations as CAR-T cells: activation, spinoculation (without lentivirus), and expansion. These T cells are meant to be negative controls in experiments using lentivirus-transduced primary CAR-T cells.

Human Normal Peripheral Blood CD4+/CD25+ Regulatory T Cells (T reg), Fresh
PBCD4-25-F2M	101Bio	-	Ask for price

Human Normal Peripheral Blood CD4+/CD25+ Regulatory T Cells (T reg), Cryopreserved
PBCD4-25-C2M	101Bio	-	Ask for price

Human Cord Blood CD34+ Cells Derived Endothelial Cells
HEC23	Neuromics	500,000+ Cells	EUR 1296

Anti-CD19 CAR-T Cells
78171-1	BPS Bioscience	1 vial	EUR 1595
Description: The anti-CD19 CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3ζ; SIN Vector, BPS Bioscience, #78601). These ready-to use CAR-T cells express an anti-CD19 CAR consisting the ScFv of CD19 (clone FMC63) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains. These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays.

Anti-CD19 CAR-T Cells
78171-2	BPS Bioscience	5 vials	EUR 4250
Description: The anti-CD19 CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3ζ; SIN Vector). These ready-to use CAR-T cells express an anti-CD19 CAR consisting the ScFv of CD19 (clone FMC63) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains.These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays.

Anti-BCMA CAR-T Cells
78660-1	BPS Bioscience	1 vial	EUR 1595
Description: The anti-BCMA CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-BCMA CAR Lentivirus (BPS Bioscience #78655). These ready-to-use CAR-T cells express an anti-BCMA CAR consisting of the ScFv of BCMA (clone C11D5.3) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains (Figure 1). These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays.

Anti-BCMA CAR-T Cells
78660-2	BPS Bioscience	5 vials	EUR 4250
Description: The anti-BCMA CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-BCMA CAR Lentivirus (BPS Bioscience #78655). These ready-to-use CAR-T cells express an anti-BCMA CAR consisting of the ScFv of BCMA (clone C11D5.3) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains (Figure 1). These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays.

anti-CD4 T helper cells
502-A-01mg	Virogen	0,1 mg	EUR 321
Description: anti-CD4 T helper cells

anti-CD4 T helper cells
502-A-1000ug	Virogen	1000 ug	EUR 1539
Description: anti-CD4 T helper cells

anti-CD4 T helper cells
502-A-100ugvial	Virogen	100 ug/vial	EUR 150
Description: anti-CD4 T helper cells

Human T- cell- interacting, activating receptor on myeloid cells
ELI-41653h	Lifescience Market	96 Tests	EUR 988.8

Immortalized Human Mucosal Associated Invariant T Cells (EM-C5)
T0706	ABM	1x106 cells / 1.0 ml	Ask for price

Immortalized Human Mucosal Associated Invariant T Cells (JK-A8)
T0708	ABM	1x106 cells / 1.0 ml	Ask for price

Immortalized Human Mucosal Associated Invariant T Cells (MG-A4)
T0709	ABM	1x106 cells / 1.0 ml	Ask for price

Immortalized Human Mucosal Associated Invariant T Cells (EM-B11)
T0705	ABM	1x106 cells / 1.0 ml	Ask for price

Immortalized Human Mucosal Associated Invariant T Cells (IK-B12)
T0707	ABM	1x106 cells / 1.0 ml	Ask for price

Human Schwann Cells
HMP303	Neuromics	500,000 Cells - Frozen	EUR 1420.8

anti-CD8 T cytotoxic/supressor cells
505-A-01mg	Virogen	0,1 mg	EUR 321
Description: anti-CD8 T cytotoxic/supressor cells

anti-CD8 T cytotoxic/supressor cells
505-A-1000ug	Virogen	1000 ug	EUR 1539
Description: anti-CD8 T cytotoxic/supressor cells

anti-CD8 T cytotoxic/supressor cells
505-A-100ugvial	Virogen	100 ug/vial	EUR 150
Description: anti-CD8 T cytotoxic/supressor cells

Human Nuclear factor of activated T- cells 5, NFAT5 ELISA KIT
ELI-39512h	Lifescience Market	96 Tests	EUR 988.8

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC942884-100	Biotium	100uL	EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF594 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC942884-500	Biotium	500uL	EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF594 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC802884-100	Biotium	100uL	EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF680 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC802884-500	Biotium	500uL	EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF680 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC702884-100	Biotium	100uL	EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF770 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC702884-500	Biotium	500uL	EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF770 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC882884-100	Biotium	100uL	EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF488A conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC882884-500	Biotium	500uL	EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF488A conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC812884-100	Biotium	100uL	EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF680R conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC812884-500	Biotium	500uL	EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF680R conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC402884-100	Biotium	100uL	EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF640R conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC402884-500	Biotium	500uL	EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF640R conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC052884-100	Biotium	100uL	EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF405M conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC052884-500	Biotium	500uL	EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF405M conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC042884-100	Biotium	100uL	EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF405S conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC042884-500	Biotium	500uL	EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF405S conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNCAP2884-100	Biotium	100uL	EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNCAP2884-500	Biotium	500uL	EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNCA2884-250	Biotium	250uL	EUR 472.8
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), APC conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNCP2884-250	Biotium	250uL	EUR 472.8
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), PerCP conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNCR2884-250	Biotium	250uL	EUR 472.8
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), RPE conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNCH2884-100	Biotium	100uL	EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNCH2884-500	Biotium	500uL	EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNCB2884-100	Biotium	100uL	EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Biotin conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNCB2884-500	Biotium	500uL	EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Biotin conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNUB2884-100	Biotium	100uL	EUR 316.8
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Concentration: 0.2mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNUB2884-50	Biotium	50uL	EUR 486
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), 1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNUB2884-500	Biotium	500uL	EUR 615.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Concentration: 0.2mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC472884-100	Biotium	100uL	EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF647 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC472884-500	Biotium	500uL	EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF647 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC552884-100	Biotium	100uL	EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF555 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC552884-500	Biotium	500uL	EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF555 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC612884-100	Biotium	100uL	EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF660R conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC612884-500	Biotium	500uL	EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF660R conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC432884-100	Biotium	100uL	EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF543 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC432884-500	Biotium	500uL	EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF543 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC682884-100	Biotium	100uL	EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF568 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody
BNC682884-500	Biotium	500uL	EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF568 conjugate, Concentration: 0.1mg/mL

Human Melanoma antigen recognized by T- cells 1, MLANA ELISA KIT
ELI-03589h	Lifescience Market	96 Tests	EUR 988.8

Human T- cell surface glycoprotein CD3 zeta, CD247 ELISA Kit
ELI-33983h	Lifescience Market	96 Tests	EUR 988.8

Albumin Standard (2.0 mg/ml)
JB04-D001C	T-Pro Biotechnology	5*1ml/kit	EUR 162

Human Bone Marrow CD34+ Stem Cells, Fresh
BMCD34-F0.5M	101Bio	-	Ask for price

Human Bone Marrow CD34+ Stem Cells, Fresh
BMCD34-F5M	101Bio	-	Ask for price

Human Mesenchymal Stem Cells
SC00A1	Neuromics	500000	EUR 1086

CORNING®HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS, HUVEC-2 CELLS (>5X105 CELLS), 1 CRYOVIAL/PACK
354151	CORNING	1/pk	EUR 465.6
Description: Permeable Support - DL; Coated Transwells - DL

anti-CD38 Hematopoietic precursors, thymocytes, activated T-cells, plasma cells
514-A-100ugvial	Virogen	100 ug/vial	EUR 150
Description: anti-CD38 Hematopoietic precursors, thymocytes, activated T-cells, plasma cells

Immortalized Human Colon Cells
T0570	ABM	1x106 cells / 1.0 ml	Ask for price

Human Nuclear factor of activated T cells, cytoplasmic 1(NFATC1) ELISA kit
E01N0544-192T	BlueGene	192 tests	EUR 1524
Description: A competitive ELISA for quantitative measurement of Human Nuclear factor of activated T cells, cytoplasmic 1(NFATC1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Nuclear factor of activated T cells, cytoplasmic 1(NFATC1) ELISA kit
E01N0544-48	BlueGene	1 plate of 48 wells	EUR 624
Description: A competitive ELISA for quantitative measurement of Human Nuclear factor of activated T cells, cytoplasmic 1(NFATC1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Nuclear factor of activated T cells, cytoplasmic 1(NFATC1) ELISA kit
E01N0544-96	BlueGene	1 plate of 96 wells	EUR 822
Description: A competitive ELISA for quantitative measurement of Human Nuclear factor of activated T cells, cytoplasmic 1(NFATC1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Immortalized Human Lingual Cells
T0042	ABM	1x106 cells / 1.0 ml	Ask for price

Immortalized Human Dendritic Cells
T0525	ABM	1x106 cells / 1.0 ml	Ask for price

Immortalized Human Mesangial Cells
T0612	ABM	1x106 cells / 1.0 ml	Ask for price

Jurkat Nuclear Extract (Acute T cell leukemia cells)
NJKT-100	Alpha Diagnostics	100 ug	EUR 196.8

Jurkat Nuclear Extract (Acute T cell leukemia cells)
NJKT-50	Alpha Diagnostics	50 ug	EUR 153.6

Human ES2 / GFP Stable Cells
SC066-G	GenTarget	2 x 106 cell/ml x 1ml	EUR 1800
Description: GFP expression stable cell line in Human ES2 cells with Puromycin resistance

Human ES2 / RFP Stable Cells
SC066-R	GenTarget	2 x 106 cell/ml x 1ml	EUR 1800
Description: RFP expression stable cell line in Human ES2 cells with Puromycin resistance

Normal Human Peripheral Blood Mononuclear Cells, Frozen -100 million cells
79059-2	BPS Bioscience	100 million cells	EUR 580
Description: Cryopreserved vial (30 x 10^6 cells) of freshly isolated primary human peripheral blood mononuclear cells (PBMCs) from a healthy donor, isolated from leukapheresis / apheresis samples using Ficoll gradient. After isolation, the PBMCs were stained to identify sub populations and evaluated for viability by flow cytometry. Cells were cryopreserved in serum-free Cryostor CS10 at a controlled rate.

Immortalized Human Testicular Cells
T0603	ABM	1x106 cells / 1.0 ml	Ask for price

Immortalized Human Urothelial Cells
T0619	ABM	1x106 cells / 1.0 ml	Ask for price

Immortalized Mouse CD4+ CD8+ T Cells (MOHITO)
T0131	ABM	1x106 cells / 1.0 ml	Ask for price

Human Bone Marrow CD34+ Stem Cells, Cryopreserved
BMCD34-C0.5M	101Bio	-	Ask for price

Human Bone Marrow CD34+ Stem Cells, Cryopreserved
BMCD34-C1M	101Bio	-	Ask for price

Human Bone Marrow CD34+ Stem Cells, Cryopreserved
BMCD34-C5M	101Bio	-	Ask for price

Immortalized Human Oropharyngeal Cells
T0041	ABM	1x106 cells / 1.0 ml	Ask for price

anti-Transferrin receptor on activated T-B- cells
518-A-01mg	Virogen	0,1 mg	EUR 321
Description: anti-Transferrin receptor on activated T-B-, cells

anti-Transferrin receptor on activated T-B- cells
518-A-1000ug	Virogen	1000 ug	EUR 1539
Description: anti-Transferrin receptor on activated T-B-, cells

The number of woven bones and the formation of the same cartilage (Huo Stage 6-7) was observed in the 3rd week after surgery in the human rights group (+) and at 6 weeks after human rights operations (-). The diameter of the callus was larger in the human rights group (+) and the difference was statistically significant (P <0.05) at 3 and 6 weeks after surgery. Although there were only statistically significant differences (P <0.05) in the 3rd week after surgery, the radiological score tended to be higher in the human rights group (+) in both weeks and 6th week after surgery. Cheap alternatives and easily accessible biological materials. Human rights can be used to support the treatment of fracture surgery, especially where bone healing is expected to last longer.